Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt

Table 1 Patient demographics and clinical data of retrospectively screened cohort

Characteristic	Value
Age1	55 (19, 54, 84)
Female	28 (20.7)
Male	107 (79.3)
Etiology of cirrhosis
Alcoholic	114 (84.4)
NASH	7 (5.2)
BCS	4 (3.0)
Kryptogenic	3 (2.2)
HCV	2 (1.5)
PBC	1 (0.7)
Autoimmune	1 (0.7)
Hemochromatosis	1 (0.7)
HBV	1 (0.7)
Toxic	1 (0.7)
Indications for TIPS
RA	83 (61.5)
RVB	38 (28.4)
HRS	10 (7.5)
BCS	3 (2.2)
Others	1 (0.7)
Technique
MHV-RPV	107 (79.3)
RHV-RPV	15 (11.1)
LHV-LPV	2 (1.5)
MHV-LPV	1 (0.7)
Unknown	10 (7.4)
Time with TIPS2	7 (0, 19, 148)
Revision
No revision	105 (77.8)
1 revision	28 (20.7)
More than 1 revision	2 (1.5)
Indications for revision
Encephalopathy	8 (26.7)
Low shunt flow	8 (26.7)
Thrombosis	14 (46.7)
End of follow-up
Loss to follow-up	99 (73.3)
Death with TIPS	20 (14.8)
Consecutive LTx	17 (12.6)

¹At TIPS-placement in years; median; min; mean; max;

²At end of screening; in months; median; min; mean; max. NASH: Non alcoholic steatohepatitis; BCS: Budd Chiari Syndrome; HCV: Hepatitis C; PBC: Primary biliary cholangits; HBV: Hepatitis B; RA: Refractory ascites; HRS: Hepatorenal syndrome; MHV: Medial hepatic vein; RPV: Right portal branch; RHV: Right hepatic vein; RVB: Refractory variceal bleeding; LHV: Left hepatic vein; LPV: Left portal branch; LTx: Liver transplantation; TIPS: Transjugular intrahepatic portosystemic shunt.